George Fitzgerald

General Counsel at Mytogen, Inc.

Health Technology

Consumer Services

Health Services

Profile

George Fitzgerald is Vice President of Regulatory and Quality Assurance for Mytogen, Inc. Previously, he was Director of Toxicology for Toxikon Corp.
and an Associate Director of the Dermatologic Oncology Department for the Dana Farber Cancer Institute.
Dr. Fitzgerald received a PhD from Purdue University.

George Fitzgerald active positions

Companies	Position	Start
Mytogen, Inc. Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA.	General Counsel	-

All active positions of George Fitzgerald

Former positions of George Fitzgerald

Companies	Position	End
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.	Corporate Officer/Principal	-

See the detail of George Fitzgerald's experience

Training of George Fitzgerald

Purdue University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of George Fitzgerald's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Mytogen, Inc. Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA.	Health Technology
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.	Health Services